In a recent article in Pharmaceutical Manufacturing and Packing Sourcer (PMPS), Smithers expert Michael Creese explores the challenging timeframes associated with extractables and leachables (E&L) testing
. Over the last few years, efficiencies have been found, notably around how risk management can help with a fast evaluation of E&L
. He also highlights what the next steps may be for the future of E&L testing
Download the article below to find out more, and for more guidance on how Smithers can support with E&L testing
please contact an expert.
This article is taken from Pharmaceutical Manufacturing and Packing Sourcer May 2021, pages 47-49. © Samedan Ltd
Download the article: